Introduction: Healthcare is at a tipping point. With ageing populations, rising chronic conditions, and growing mental health needs, traditional reactive models are no longer sufficient. Social prescribing connecting people to community-based support has already begun transforming lives. Now, artificial intelligence (AI) is unlocking a new era of digital health, enabling prevention, personalisation, and equity at scale.
Global Opportunity: Through the Global Social Prescribing Alliance (GSPA), social prescribing is expanding across 40 countries, supporting millions of people with mental health support, lifestyle interventions, and social wellbeing services.
Meanwhile, the digital health market is booming. Estimates for 2026 range from $177 billion to over $480 billion, with projections to exceed $1 trillion by the early 2030s, driven by telehealth, AI platforms, wearable technology, and mobile health apps.
AI in Action: AI is enhancing social prescribing across multiple domains:
- In primary care, predictive analytics identify patients at risk, enabling early referral to community services.
- In mental health, conversational AI platforms streamline triage and reduce waiting times.
- Among older adults, AI detects loneliness, allowing link workers to facilitate meaningful community engagement.
- For long-term conditions, AI-driven behaviour coaching supports self-management.
- At a population level, AI analyses hotspots of unmet need to target interventions effectively.
Why it Matters: As Gareth Presch, CEO of GSPA, says:
“AI should not replace the human element of social prescribing — it is an enabler. It allows us to reach more people, personalise interventions, and measure impact, while ensuring communities thrive.”
By integrating AI responsibly, social prescribing can maintain its human-centred approach, measure outcomes, reduce system strain, and address health inequalities.
Looking Ahead: Policymakers, healthcare providers, and investors have a unique opportunity to embrace AI in social prescribing. By prioritising ethical design, data governance, and inclusive access, we can ensure that the benefits of digital health innovation reach everyone.
Reference: This blog draws on insights from the GSPA Policy Paper: “Artificial Intelligence in Digital Health and Social Prescribing” (2026).